Professional Marketing briefs

Share this article:
Sanofi-Aventis settled a lawsuit accusing the company of underpaying 4,000 female reps in the US, and will pay $15.4 million as part of the settlement. Affected reps will see an increase in their base pay as a result of the settlement. Meanwhile a Novartis rep prevailed in her suit against the company, which she accused of slashing her territory and eliminating her position in retaliation for having taken maternity leave.

Valeant Pharmaceuticals entered into an agreement with Spear Pharmaceuticals for rights to commercialize Refissa, a prescription wrinkle and sun damage cream. Valeant will pay $12 million and the companies will share netprofit.

Arena Pharmaceuticals is looking for a commercial partner for its weight loss drug lorcaserin, pending approval, but will launch without if need be, the company told Reuters. The company is competing with Vivus Inc and Orexigen Therapeutics for first-to-market status.
Share this article:
close

Next Article in Features

Email Newsletters

More in Features

Headliner: Proteus CEO takes an original path

Headliner: Proteus CEO takes an original path

Andrew Thompson, CEO, Proteus Digital Health

Leadership Exchange: How Do We Get Beyond the Pill?

Leadership Exchange: How Do We Get Beyond the ...

As its focus moves from manufacturing to service, pharma needs to partner with healthcare neophytes as well as established players. James Chase asks six experts to assess the risks and ...

FDA and off-label uses: a balancing act

FDA and off-label uses: a balancing act

FDA's current re-examination of its off-label promotion policies in light of the First Amendment is a delicate balancing act between its rock-solid traditional enforcement posture and a diverse new electronic ...